HealthcareStartups

CoMind Secures $60M Investment for Non-Invasive Brain Monitoring Technology

CoMind, a London-based healthtech startup, has reportedly secured $60 million in funding to advance its non-invasive brain monitoring technology. The company’s device uses low-powered infrared lasers to measure cerebral blood flow and pressure without skull penetration. Sources indicate this funding round brings CoMind’s total investment to over $102 million.

Major Funding for Brain Monitoring Innovation

London-based healthtech startup CoMind has reportedly secured $60 million in a recent funding round, according to financial reports. The investment was led by Plural, an early-stage venture firm with operations in London and Tallinn, with participation from several other prominent investors.

Arts and EntertainmentManufacturing

AI Tool SpectroGen Revolutionizes Material Quality Control with Virtual Spectrometer

A groundbreaking AI tool developed by MIT engineers is transforming material quality verification by generating accurate spectral data across different modalities. SpectroGen achieves 99% correlation with physical measurements while reducing verification time from hours to under a minute.

The Material Quality Control Revolution

In industries ranging from electronics to pharmaceuticals, verifying material quality has traditionally represented a significant bottleneck in development pipelines. The process typically requires multiple specialized instruments, extensive laboratory space, and considerable time investments – often stretching verification processes across several days. This challenge has persisted even as artificial intelligence has accelerated material discovery, creating an imbalance between identification and validation capabilities.